Literature DB >> 8986789

DNA damage and p53-mediated cell cycle arrest: a reevaluation.

N S Pellegata1, R J Antoniono, J L Redpath, E J Stanbridge.   

Abstract

Most mammalian cells exhibit transient delays in the G1 and G2 phases of the cell cycle after treatment with radiation or radiomimetic compounds. p53 is required for the arrest in G1, which provides time for DNA repair. Recently, a role of p53 in the G2/M transition has also been suggested. However, it has been reported that the presence of functional p53 does not always correlate with the induction of these checkpoints. To precisely assess the role of p53 in activating cell cycle checkpoints and in cell survival after radiation, we studied the response of two isogenic human fibrosarcoma cell lines differing in their p53 status (wild type or mutant). We found that when irradiated cells undergo a wild-type p53-dependent G1 arrest, they do not subsequently arrest in G2. Moreover, wild-type p53 cells irradiated past the G1 checkpoint arrest in G2 but do not delay in the subsequent G1 phase. Furthermore, in these cell lines, which do not undergo radiation-induced apoptosis, the wild-type p53 cell line exhibited a greater radioresistance in terms of clonogenic survival. These results suggest that the two checkpoints may be interrelated, perhaps through a control system that determines, depending on the extent of the damage, whether the cell needs to arrest cell cycle progression at the subsequent checkpoint for further repair. p53 could be a crucial component of this control system.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8986789      PMCID: PMC26382          DOI: 10.1073/pnas.93.26.15209

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

Review 1.  Checkpoints: controls that ensure the order of cell cycle events.

Authors:  L H Hartwell; T A Weinert
Journal:  Science       Date:  1989-11-03       Impact factor: 47.728

2.  Cancer. p53, guardian of the genome.

Authors:  D P Lane
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

3.  Loss of oncogenic ras expression does not correlate with loss of tumorigenicity in human cells.

Authors:  R Plattner; M J Anderson; K Y Sato; C L Fasching; C J Der; E J Stanbridge
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

4.  Diminished capacity for p53 in mediating a radiation-induced G1 arrest in established human tumor cell lines.

Authors:  C Y Li; H Nagasawa; W K Dahlberg; J B Little
Journal:  Oncogene       Date:  1995-11-02       Impact factor: 9.867

5.  Participation of p53 protein in the cellular response to DNA damage.

Authors:  M B Kastan; O Onyekwere; D Sidransky; B Vogelstein; R W Craig
Journal:  Cancer Res       Date:  1991-12-01       Impact factor: 12.701

6.  p21 is necessary for the p53-mediated G1 arrest in human cancer cells.

Authors:  T Waldman; K W Kinzler; B Vogelstein
Journal:  Cancer Res       Date:  1995-11-15       Impact factor: 12.701

7.  Cell cycle synchrony unmasks the influence of p53 function on radiosensitivity of human glioblastoma cells.

Authors:  G L Yount; D A Haas-Kogan; C A Vidair; M Haas; W C Dewey; M A Israel
Journal:  Cancer Res       Date:  1996-02-01       Impact factor: 12.701

8.  Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis.

Authors:  A F Wahl; K L Donaldson; C Fairchild; F Y Lee; S A Foster; G W Demers; D A Galloway
Journal:  Nat Med       Date:  1996-01       Impact factor: 53.440

9.  p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts.

Authors:  M L Agarwal; A Agarwal; W R Taylor; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

10.  p53 modulation of TFIIH-associated nucleotide excision repair activity.

Authors:  X W Wang; H Yeh; L Schaeffer; R Roy; V Moncollin; J M Egly; Z Wang; E C Freidberg; M K Evans; B G Taffe
Journal:  Nat Genet       Date:  1995-06       Impact factor: 38.330

View more
  50 in total

1.  Repression of CDK1 and other genes with CDE and CHR promoter elements during DNA damage-induced G(2)/M arrest in human cells.

Authors:  C Badie; J E Itzhaki; M J Sullivan; A J Carpenter; A C Porter
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

2.  Cell proliferation and DNA breaks are involved in ultraviolet light-induced apoptosis in nucleotide excision repair-deficient Chinese hamster cells.

Authors:  Torsten R Dunkern; Bernd Kaina
Journal:  Mol Biol Cell       Date:  2002-01       Impact factor: 4.138

3.  Nijmegen breakage syndrome cells fail to induce the p53-mediated DNA damage response following exposure to ionizing radiation.

Authors:  W Jongmans; M Vuillaume; K Chrzanowska; D Smeets; K Sperling; J Hall
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

4.  Varying responses of human cells with discrepant p53 activity to ionizing radiation and heat shock exposure.

Authors:  S V Tokalov; S Pieck; H O Gutzeit
Journal:  Cell Prolif       Date:  2007-02       Impact factor: 6.831

Review 5.  Cell cycle control as a basis for cancer chemoprevention through dietary agents.

Authors:  Syed Musthapa Meeran; Santosh Kumar Katiyar
Journal:  Front Biosci       Date:  2008-01-01

Review 6.  Host nucleotide polymorphism in hepatitis B virus-associated hepatocellular carcinoma.

Authors:  Shilu Mathew; Hany Abdel-Hafiz; Abbas Raza; Kaneez Fatima; Ishtiaq Qadri
Journal:  World J Hepatol       Date:  2016-04-08

7.  Adenovirus type 12-induced fragility of the human RNU2 locus requires p53 function.

Authors:  Z Li; A Yu; A M Weiner
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

Review 8.  Pathologies associated with the p53 response.

Authors:  Andrei V Gudkov; Elena A Komarova
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-04-07       Impact factor: 10.005

9.  Temporal events in skin injury and the early adaptive responses in ultraviolet-irradiated mouse skin.

Authors:  A Ouhtit; H K Muller; D W Davis; S E Ullrich; D McConkey; H N Ananthaswamy
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

10.  Induced pluripotent stem cells have similar immunogenic and more potent immunomodulatory properties compared with bone marrow-derived stromal cells in vitro.

Authors:  Lauren V Schnabel; Christian M Abratte; John C Schimenti; M Julia Bevilaqua Felippe; Jennifer M Cassano; Teresa L Southard; Jessica A Cross; Lisa A Fortier
Journal:  Regen Med       Date:  2014-04-28       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.